JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Search results for: 'signaling pathways cardiovascular {{media url='

Search results for: 'signaling pathways cardiovascular {{media url='

A8314 Temsirolimus

Summary: MTOR inhibitor

≥51.5 mg/mL
A8318 PP242

Target: mTOR

Summary: MTOR inhibitor, selective and ATP-competitive
A8346 BYL-719
1 Citation

Target: PI3K

Summary: Selective PI3Kα inhibitor

≥22.07 mg/mL
A8541 Triciribine
5 Citation

Summary: Akt inhibitor,highly selective

insoluble in H2O; insoluble in EtOH; ≥118.4 mg/mL
A8616 A-674563

Target: Cyclin-Dependent Kinases|Akt|GSK-3|ERK|PKC|PKA|RSK

Summary: Akt1/PKA/CDK2 inhibitor,potent and selective

insoluble in EtOH; ≥23.8 mg/mL
A8617 CCT128930 HCl

Target: Akt

Summary: AKT inhibitor

insoluble in H2O; ≥17.1 mg/mL
A8618 Palomid 529

Summary: PI3K/Akt/mTOR inhibitor

insoluble in EtOH; insoluble in H2O; ≥41 mg/mL
A8619 TIC10

Summary: Potent Akt/ERK inhibitor
A8167 Rapamycin (Sirolimus)
15 Citation

Target: mTOR

Summary: Original antifungal antibiotic

≥45.7 mg/mL
A8169 Everolimus (RAD001)
8 Citation

Target: mTOR

Summary: MTOR inhibitor

≥47.91 mg/mL